Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Bevenopran for Opioid-Induced Constipation
NCT01696643Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bevenopran in opioid-induced constipation (OIC), sponsored by Merck & Co.. Started Oct 2012; status: terminated.
02
Drugs
bevenopran
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01696643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696643.